Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Multiple Myeloma 27Breast Neoplasms 23Neoplasms 22Pancreatic Neoplasms 19Prostatic Neoplasms 17Glioma 17Glioblastoma 16Leukemia, Myeloid, Acute 15Recurrence 14Solid Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma 8Hematologic Neoplasms 8Melanoma 7Lymphoma, B-Cell 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Advanced Solid Tumors 7Polycystic Ovary Syndrome 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Stomach Neoplasms 5Myelodysplastic Syndromes 5Leukemia, Plasma Cell 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × Advanced Lung Cancer × Clear all
NCT06928922 2026-01-13

Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase EARLY_PHASE1 Recruiting
83 enrolled
Thoracic

Advanced Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡